Home > Insider Trading > Filing (0001104659-24-097254)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1671502	Quoin Pharmaceuticals Ltd.	QNRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1959547	Michael Myers	C/O Quoin Pharmaceuticals Ltd. 42127 Pleasant Forest Court Ashburn VA 20148	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2024-09-03	800	$0.62	10,158	No	4	P	Direct
Ordinary Shares	Acquisiton	2024-09-04	5,322	$0.66	15,480	No	4	P	Direct
Ordinary Shares	Acquisiton	2024-09-04	8,200	$0.75	23,680	No	4	P	Direct
Ordinary Shares	Acquisiton	2024-09-04	23,572	$0.80	47,252	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
Effective July 18, 2023, the ratio of ADSs evidencing ordinary shares changed from 1 ADS representing five thousand (5,000) ordinary shares to 1 ADS representing sixty thousand (60,000) ordinary shares, which resulted in a 1 for 12 reverse split of the issued and outstanding ADSs. Effective November 8, 2023, the Issuer completed a 1 for 60,000 reverse split of the ordinary shares which resulted in the ratio of ADSs evidencing ordinary shares to be changed from 1 ADS representing sixty thousand (60,000) ordinary shares to 1 ADS representing one (1) ordinary share. The amount of ordinary shares reported in this column includes ordinary shares previously included in the Reporting Person's Form 3, adjusted to reflect the number of ordinary shares resulting from the 1 for 60,000 reverse split effective November 8, 2023.